Physician profile
Jay Patchen
NPI 1619940509
$2,721.83
in general payments reported to CMS, 2019-2025
20 companies · $323 in 2025
The $323 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,140 · 2020: $180 · 2021: $228 · 2022: $168 · 2023: $160 · 2024: $522 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $745.66 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $550.63 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.16 | 2019-2025 | Synjardy, Jardiance |
| Sanofi-Aventis U.S. LLC | $261.57 | 2019-2023 | |
| Lilly USA, LLC | $169.96 | 2022-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $115.31 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $114.12 | 2019-2025 | Capvaxive, Gardasil 9 |
| Pfizer INC. | $111.28 | 2019-2022 | |
| Glaxosmithkline, LLC. | $75.07 | 2019-2023 | Shingrix, Arexvy |
| Daiichi Sankyo INC. | $56.36 | 2019-2025 | Injectafer |
| Exact Sciences Corporation | $47.85 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $44.57 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.97 | 2022-2023 | |
| Abbvie INC. | $30.31 | 2022-2025 | |
| Arbor Pharmaceuticals, INC. | $17.61 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $17.33 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Mannkind Corporation | $16.79 | 2019 | |
| Allergan, INC. | $15.47 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.55 | 2019 | |
| Roche Diabetes Care, INC. | $14.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patchen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.